Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Abstract 2338: BRAF inhibition is associated with increased clonality of tumor infiltrating lymphocytes.

Zachary A. Cooper, Dennie T. Frederick, Ryan J. Sullivan, Donald P. Lawrence, Adriano Piris, Keith T. Flaherty, David A. Fisher, Jennifer A. Wargo

Cancer Res (2013) 73 (8_Supplement): 2338.

https://doi.org/10.1158/1538-7445.AM2013-2338

Published: 15 April 2013

View articletitled, Abstract 2338: BRAF inhibition is associated with increased clonality of tumor infiltrating lymphocytes.

Journal Articles

Abstract 4568: Rapid assessment of TORC1 suppression predicts responsiveness to RAF and MEK inhibition in BRAF mutant melanoma.

Ryan B. Corcoran, Stephen M. Rothenberg, Aaron N. Hata, Anthony C. Faber, Daniel Winokur, Adriano Piris, Rosalynn M. Nazarian, Ronald D. Brown, Jason T. Godfrey, Mari Mino-Kenudson, Jeffrey Settleman, Jennifer A. Wargo, Keith T. Flaherty, Daniel A. Haber, Jeffrey A. Engelman

Cancer Res (2013) 73 (8_Supplement): 4568.

https://doi.org/10.1158/1538-7445.AM2013-4568

Published: 15 April 2013

View articletitled, Abstract 4568: Rapid assessment of TORC1 suppression predicts responsiveness to RAF and MEK inhibition in BRAF mutant melanoma.

Journal Articles

Abstract LB-350: EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition by vemurafenib

Ryan B. Corcoran, Hiromichi Ebi, Alexa B. Turke, Erin M. Coffee, Michiya Nishino, Alexandra P. Cogdill, Ronald D. Brown, Dora Dias-Santagata, Patricia Della Pelle, Kenneth E. Hung, Keith T. Flaherty, Adriano Piris, Jennifer A. Wargo, Jeffrey Settleman, Mari Mino-Kenudson, Jeffrey A. Engelman

Cancer Res (2012) 72 (8_Supplement): LB-350.

https://doi.org/10.1158/1538-7445.AM2012-LB-350

Published: 15 April 2012

View articletitled, Abstract LB-350: EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition by vemurafenib

Journal Articles

Abstract 958: Treatment with a selective inhibitor of BRAFV600E increases melanocyte antigen expression and CD8 T cell infiltrate in tumors of patients with metastatic melanoma

Jennifer A. Wargo, Alex Cogdill, Ping Dang, Ridhi Gupta, Adriano Piris, Andrea Boni, Haven R. Garber, Harald Ott, Lindsay P. Newton, Keith T. Flaherty, Donald P. Lawrence, Hensin Tsao, David E. Fisher

Cancer Res (2011) 71 (8_Supplement): 958.

https://doi.org/10.1158/1538-7445.AM2011-958

Published: 15 April 2011

View articletitled, Abstract 958: Treatment with a selective inhibitor of BRAFV600E increases melanocyte antigen expression and CD8 T cell infiltrate in tumors of patients with metastatic melanoma

Journal Articles

Dynamic Gene Expression Analysis Links Melanocyte Growth Arrest with Nevogenesis

Guang Yang, Khanh Thieu, Kenneth Y. Tsai, Adriano Piris, Durga Udayakumar, Ching-Ni Jenny Njauw, Marco F. Ramoni, Hensin Tsao

Cancer Res (2009) 69 (23): 9029–9037.

https://doi.org/10.1158/0008-5472.CAN-09-0783

Published: 30 November 2009

View articletitled, Dynamic Gene Expression Analysis Links Melanocyte Growth Arrest with Nevogenesis

Includes: Supplementary data

Journal Articles

Apoptosis Protease Activator Protein-1 Expression Is Dispensable for Response of Human Melanoma Cells to Distinct Proapoptotic Agents

Marina Zanon, Adriano Piris, Ilaria Bersani, Claudia Vegetti, Alessandra Molla, Alessia Scarito, Andrea Anichini

Cancer Res (2004) 64 (20): 7386–7394.

https://doi.org/10.1158/0008-5472.CAN-04-1640

Published: 15 October 2004

View articletitled, Apoptosis Protease Activator Protein-1 Expression Is Dispensable for Response of Human Melanoma Cells to Distinct Proapoptotic Agents

Journal Articles

Lack of Terminally Differentiated Tumor-specific CD8⁺ T Cells at Tumor Site in Spite of Antitumor Immunity to Self-Antigens in Human Metastatic Melanoma

Roberta Mortarini, Adriano Piris, Andrea Maurichi, Alessandra Molla, Ilaria Bersani, Aldo Bono, Cesare Bartoli, Mario Santinami, Claudia Lombardo, Fernando Ravagnani, Natale Cascinelli, Giorgio Parmiani, Andrea Anichini

Cancer Res (2003) 63 (10): 2535–2545.

Published: 15 May 2003

View articletitled, Lack of Terminally Differentiated Tumor-specific CD8+ T Cells at Tumor Site in Spite of Antitumor Immunity to Self-Antigens in Human Metastatic Melanoma

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract 2338: BRAF inhibition is associated with increased clonality of tumor infiltrating lymphocytes.

Abstract 4568: Rapid assessment of TORC1 suppression predicts responsiveness to RAF and MEK inhibition in BRAF mutant melanoma.

Abstract LB-350: EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition by vemurafenib

Abstract 958: Treatment with a selective inhibitor of BRAFV600E increases melanocyte antigen expression and CD8 T cell infiltrate in tumors of patients with metastatic melanoma

Dynamic Gene Expression Analysis Links Melanocyte Growth Arrest with Nevogenesis

Apoptosis Protease Activator Protein-1 Expression Is Dispensable for Response of Human Melanoma Cells to Distinct Proapoptotic Agents

Lack of Terminally Differentiated Tumor-specific CD8⁺ T Cells at Tumor Site in Spite of Antitumor Immunity to Self-Antigens in Human Metastatic Melanoma

Email alerts

AACR Journals

Update search

Abstract 2338: BRAF inhibition is associated with increased clonality of tumor infiltrating lymphocytes.

Abstract 4568: Rapid assessment of TORC1 suppression predicts responsiveness to RAF and MEK inhibition in BRAF mutant melanoma.

Abstract LB-350: EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition by vemurafenib

Abstract 958: Treatment with a selective inhibitor of BRAFV600E increases melanocyte antigen expression and CD8 T cell infiltrate in tumors of patients with metastatic melanoma

Dynamic Gene Expression Analysis Links Melanocyte Growth Arrest with Nevogenesis

Apoptosis Protease Activator Protein-1 Expression Is Dispensable for Response of Human Melanoma Cells to Distinct Proapoptotic Agents

Lack of Terminally Differentiated Tumor-specific CD8+ T Cells at Tumor Site in Spite of Antitumor Immunity to Self-Antigens in Human Metastatic Melanoma

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only

Lack of Terminally Differentiated Tumor-specific CD8⁺ T Cells at Tumor Site in Spite of Antitumor Immunity to Self-Antigens in Human Metastatic Melanoma